20 results
home > search results
search results

20 results for tag "news".

TriOptima and LCH.Clearnet’s SwapClear are cooperating to terminate cleared interest rate trades for SwapClear’s members. They have been conducting regular multilateral triReduce termination cycles which result in elim

TriOptima was selected by the ISDA Rates Steering Committee to provide the Global Interest Rate Trade Reporting Repository (Rates Repository) in October 2009. The Rates Repository went live in January and started posting public re

TriOptima’s triResolve counterparty exposure management service continues to attract new subscribers from the buy side where they find all their G-14 counterparties already performing daily reconciliations.

In January 2011, ISDA published the Asia Pacific Collateralized Portfolio Reconciliation Memorandum of Understanding (MoU) which was the result of two pilot programs sponsored by the ISDA Asia Pacific Collateral Management Operati

A paper published on February 23, 2012 by The International Swaps and Derivatives Association, Inc. (ISDA), “Interest Rate Swaps Compression: A Progress Report” discusses TriOptima’s portfolio compression service

TriOptima has won the Energy Risk Technology House of the Year award for its innovative triReduce and triResolve technologies. Over the past year TriOptima has increased its focus on the energy sector in anticipation of

J.P. Morgan’s Agency Clearing, Collateral Management and Execution (ACCE) business has introduced daily portfolio reconciliation for its derivatives collateral management clients. The product, available through ACCEs TriOp

On March 18th, CFTC’s Division of Clearing and Risk issued a No-Action Relief from required clearing of swaps that are generated as part of multilateral portfolio compression exercises, including both partially terminated sw

TriOptima will be hosting a series of regional roundtables on the outlined CFTC and EMIR regulations. The implications of the new rules will be discussed and you will find out what the industry is doing to comply with the requirem

On 30 January, the European Securities and Markets Authority (ESMA) published 2nd Update of Q&A on the application of the Short Selling Regulation(SSR) which clarified that replacement trades resulting from compressions are no

  CFTC No-Action Letter No. 12-62 Compression exercise swap transactions full and partial unwinds, as well as replacement trades resulting from multilateral portfolio compression exercises, will not count towards

The EU Commission and the CFTC announced an agreement on the treatment of cross border derivatives on July 11, 2013 that covers both entity and transaction level requirements in Dodd Frank and EMIR. The joint announcement from t

Banks compress trades to comply with Basel III Banks are working to reduce balance sheets by tearing up billions of dollars in derivatives exposure to comply with Basel III rules.  “Compression will be a key tool for

  TriOptima has been awarded the ‘Post-Trade Platform of the Year’ award by Derivatives Week. According to its editors, the firm has once again been praised by all forms of market participants for its triReduce,

On November 20th, TriOptima was awarded the Commodities Now Business Award for Exposure Risk Mitigation.  Achievements by triReduce in commodities-related portfolio compression and triResolve in commodities community por

TriOptima launches triReduce On Demand as a complement to its regular multilateral portfolio compression cycles for OTC derivatives. With triReduce On Demand, market participants can initiate their own bilateral or internal compre

TriOptima announces that it won the Energy Risk 2014 ”Technology House of the Year" in recognition of the significant take-up of its triReduce (portfolio compression) and triResolve (portfolio reconciliation and di

TriOptima announces that its triReduce compression service has received the Risk Magazine OTC Infrastructure Service of the Year Award. The award will be presented at the Risk Awards dinner in London on the evening of 29 January,

As new trade reporting and data validation requirements are implemented by regulators, triResolve Repository Reconciliation helps clients to identify and resolve potential discrepancies in their global repository data.

triReduce’s portfolio compression and triResolve’s portfolio reconciliation and repository reconciliation help market participants achieve regulatory compliance and reduce risk exposure in their OTC derivatives portfolios.

1 2
Please enter your full name.

Interest Rate Trade Reporting Repository
Terms and Conditions for Access and Use

1. Scope of Agreement
    These terms and conditions (this "Agreement") govern your access to and use of any public repository reports of OTC interest rate derivatives (each a "Report") produced by TriOptima AB ("TriOptima"), as described on the information web page regarding the repository. You must accept this Agreement to access and use Reports. You accept the Agreement by clicking the "I Agree" button on the bottom of this page. TriOptima may at any time, without advance or specific notice, amend this Agreement. Hence, you are expected to review and accept this Agreement each time you wish to access any Report through this website.

2. Intellectual property rights, license to use
    You acknowledge that TriOptima is the sole and exclusive owner of any and all intellectual property rights to the structure and layout of any Report.

    TriOptima hereby grants to you a non-exclusive license to use Reports in accordance with this Agreement.

3. Prohibited use of Reports
    You must not use any Report or the information contained in any Report in a manner that may harm or be detrimental to TriOptima, including without limitation, to use any Report to directly or indirectly compete or promote competition with TriOptima.

    You are not allowed to use TriOptima's name or any trademarks, trade names or service marks contained in any Report or this website in advertising, publicity or otherwise; neither are you allowed to copy any marks, specific characteristics or attributes of any Report for any other purpose than for making a lawful and contractually permitted copy of a Report.

4. Non-reliance, no warranty, disclaimer
    Each Report is provided to you free of charge. However, TriOptima does not warrant or undertake to make any Reports available to you; hence you acknowledge that TriOptima, in its sole discretion, may or may not make Reports available to you via this website or otherwise.

    Each Report is intended for information purposes only. Any information in a Report may at any time be superseded or replaced by new or updated information. Furthermore, the information contained in a Report is based on the information submitted by third parties for the purpose of inclusion in such Report. The information contained in a Report is neither checked, nor verified by TriOptima. Consequently, you acknowledge that Reports are for information purposes only, that they may not be relied upon for any purpose whatsoever, and that they are dependent upon, as regards their accuracy and completeness, the data submitted to TriOptima by third parties.

    The parties acknowledge that TriOptima makes no representation or warranty with respect to any Report or this website or any data or materials retrieved, obtained, provided or transmitted, by or to you, using this website. Each Report and this website and all such data and materials are being provided to you "as is". TriOptima hereby disclaims any and all representations and warranties, whether express or implied, including without limitation, any representation or warranty as to merchantability or fitness for a particular purpose, any representations or warranties arising from course of dealing or course of performance, and any representations or warranties of accuracy, reliability or functionality.

    To the maximum extent permitted by law, TriOptima disclaims all liability arising out of or in connection with the use of any Report or this website.

    Without prejudice to the above, TriOptima shall not be liable to you, or anyone claiming under or through you, for loss of profit, or any indirect or consequential loss or damages under or in connection with this Agreement, the use of any Report or this website, including without limitation, damages for loss of capital, interest, revenue, data or use, or interruption of business, even if you had been advised of the possibility of such damages.

    Notwithstanding anything to the contrary in this Agreement, TriOptima does not exclude or limit its liability for wilful misconduct, fraud or death or personal injury arising from TriOptima's negligence.

    For purposes of this clause, references to TriOptima shall be deemed to include its affiliates and their respective partners, officers, employees, directors, agents, contractors, representatives, successors and assigns.

5. Viruses, malware
    To the best of TriOptima's knowledge, Reports published on this website, this website and the server on which it resides are free from viruses and other malware. However, TriOptima cannot warrant this to be the case, and it is your responsibility to take precautions to prevent your computer and/or network to be affected by viruses or other malware. Hence, TriOptima does not assume any liability for any damage or loss, whether direct or indirect, including loss of data, caused to you by viruses or other malware from Reports published on this website, this website or the server on which it resides, including when you download any Report.

6. Applicable law, disputes
    This Agreement and any non-contractual obligations arising in connection with it shall be governed by English law, without regard to its principles of conflicting laws. Each party submits to the exclusive jurisdiction of the English courts for all purposes relating to this Agreement (including the enforcement of any determinations).
I agree    I decline

We use cookies to ensure that you get the best possible experience of our website. By continuing the use of our website without changing your browser settings, you give your consent to our use of cookies.

To learn more about cookies, how we use them and for what purposes, and how you can manage your browser settings to reject or control use of cookies, please read our Cookie Policy